HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ronald G Gregg Selected Research

congenital stationary Night blindness

1/2017A missense mutation in Grm6 reduces but does not eliminate mGluR6 expression or rod depolarizing bipolar cell function.
11/2015Intravitreal delivery of a novel AAV vector targets ON bipolar cells and restores visual function in a mouse model of complete congenital stationary night blindness.
10/2013Ultrastructural localization of GPR179 and the impact of mutant forms on retinal function in CSNB1 patients and a mouse model.
2/2012GPR179 is required for depolarizing bipolar cell function and is mutated in autosomal-recessive complete congenital stationary night blindness.
11/2009Mutations in TRPM1 are a common cause of complete congenital stationary night blindness.
11/2007Nyctalopin expression in retinal bipolar cells restores visual function in a mouse model of complete X-linked congenital stationary night blindness.
5/2002Role of the beta(2) subunit of voltage-dependent calcium channels in the retinal outer plexiform layer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ronald G Gregg Research Topics

Disease

7congenital stationary Night blindness
01/2017 - 05/2002
3Williams Syndrome (Williams-Beuren Syndrome)
05/2010 - 11/2003
2Intellectual Disability (Idiocy)
12/2014 - 10/2010
2Supravalvular Aortic Stenosis (Aortic Supravalvular Stenosis)
05/2010 - 11/2003
2Ganglion Cysts (Ganglion)
11/2006 - 05/2002
1Hypertrophy
11/2016
1Neurodegenerative Diseases (Neurodegenerative Disease)
12/2014
1Parkinson Disease (Parkinson's Disease)
12/2014
1Cataract (Cataracts)
10/2011
1Albinism
05/2011
1Hermanski-Pudlak Syndrome (Hermansky-Pudlak Syndrome)
05/2011
1Chediak-Higashi Syndrome
05/2011
1Ocular Paraneoplastic Syndromes
03/2011
1Glaucoma
02/2011
1Leukoencephalopathies
01/2011
1type 2C Congenital disorder of glycosylation
10/2010
1Hernia (Hernias)
05/2010
1Multiple Acyl Coenzyme A Dehydrogenase Deficiency
12/2009
1Pain (Aches)
07/2009
1Epilepsy (Aura)
07/2008
1Coloboma (Colobomas)
07/2008
1Vitreoretinochoroidopathy
05/2006
1Vitelliform Macular Dystrophy
05/2006

Drug/Important Bio-Agent (IBA)

8Retinaldehyde (Retinal)IBA
10/2013 - 11/2006
2ElastinIBA
05/2010 - 11/2003
2Proteins (Proteins, Gene)FDA Link
07/2008 - 11/2007
1metabotropic glutamate receptor 6IBA
01/2017
1LipidsIBA
11/2016
1cholesterol 25-hydroxylaseIBA
11/2016
1Sterol Esterase (Hormone-Sensitive Lipase)IBA
11/2016
1GTP-Binding Proteins (G-Protein)IBA
11/2015
1SynucleinsIBA
12/2014
1Messenger RNA (mRNA)IBA
10/2011
1PlatinumIBA
05/2011
1CationsIBA
03/2011
1AutoantibodiesIBA
03/2011
1ribonuclease T(2)IBA
01/2011
1Ribosomal RNAIBA
01/2011
1Glycoproteins (Glycoprotein)IBA
10/2010
1DNA (Deoxyribonucleic Acid)IBA
05/2010
1Electron-Transferring Flavoproteins (Electron Transfer Flavoprotein)IBA
12/2009
1Oxidoreductases (Dehydrogenase)IBA
12/2009
1Membrane Proteins (Integral Membrane Proteins)IBA
07/2008
1cyclopamineIBA
07/2008
1Guanylate KinasesIBA
07/2008
1BestrophinsIBA
05/2006
1GABA-C receptor (receptor, GABA(C))IBA
05/2002
1Calcium Channels (Calcium Channel)IBA
05/2002

Therapy/Procedure

1Dental Care
07/2009